Kelly Watson is VP, Product & User Experience for Tidepool, a digital health nonprofit building solutions for people with diabetes. Kelly has worked to ensure the patient, the clinician and care partners are at the center of the product design process, leading Tidepool to achieve rapid market adoption growing its global ecosystem to nearly 400,000 people with diabetes and 12,000 clinicians. At Tidepool, she has led partnerships with many of the world’s largest diabetes medical device companies and technology companies. Previously Kelly worked in bench research at the Center for Biologics Evaluation and Research, FDA (CBER-OVRR DVP) and the National Institute of Mental Health prior to building out a product design consultancy. She is an angel investor and advisor for emerging digital health startups. Kelly advocates for patient ownership of health data, interoperability and open healthcare standards.